|Articles|November 30, 2006

Virtual reality system debuts

A virtual reality system unveiled this week allows neurosurgeons to walk through planned interventions step by step and radiologists, other specialists, and educators to discuss specific cases.

Dextrobeam projects multimodality, patient-specific CT, MR, and PET/SPECT images as 3D objects on a screen that operators can explore and manipulate using their hands. The system was developed by Singapore-based Volume Interactions, a subsidiary of the Bracco Group. At last year's meeting, the company introduced Dextroscope, an interactive workstation, which allows users to interact with 3D images

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

September 17th, 2026

The Reading Room Podcast: Assessing the Current Landscape of AI and Reimbursement in Radiology, Part 2

In the second of a two-part podcast episode, Lauren Nicola, MD, Christoph Wald, MD, PhD, MBA, and Peter Shen discuss challenges with evaluating value and ROI for AI software, the physician time required to do so, and possible solutions to facilitate improved clarity and consistency with AI reimbursement.

September 16th, 2026

Breast Imaging in Focus: Key Pearls from New Guidelines on Proliferative Breast Lesions with Atypia and LCIS

In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, offer pertinent takeaways for breast radiologists from recently issued guidelines for addressing proliferative breast lesions with atypia and lobular carcinoma in situ (LCIS).

September 15th, 2026

Brain MRI Study Reveals Higher Brain Age Gap and White Matter Hyperintensity for Those in Disadvantaged Neighborhoods

In a study involving over 2,800 people who had brain MRI scans, researchers found that people in the most disadvantaged neighborhoods had 37 percent higher white matter hyperintensity volume (WMHV) on average in comparison to people in the least disadvantaged areas.

September 15th, 2026

CT Radiation Dosing: Where Things Stand, Part 2

In the second of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed future directions for research on CT radiation dosing, including the potential of indication-specific diagnostic reference levels (DRLs).

September 14th, 2026

The Shifting Power Dynamic in Radiology: Respect and Equal Footing with Referring Clinicians

Amid the explosion of imaging volume, an emerging silver lining is increasing recognition from referring clinicians of the time and value radiologists provide to facilitate patient care.

September 14th, 2026

Molecular Imaging in Focus: Can the Newly FDA-Approved PET Agent Floretyrosine F18 Have an Impact for Glioma Imaging?

In a recent episode of our Molecular Imaging in Focus series, Thomas Hope, MD, discussed challenges with conventional imaging for gliomas and the potential of the newly FDA-approved PET agent floretyrosine F18 (18F-FET) for differentiating between glioma progression and treatment-related effects.

September 12th, 2026

Diagnostic Imaging's Weekly Scan: September 6 — September 12

Catch up on the top radiology content of the past week.

September 11th, 2026

MRI Research Reveals Strong Link Between Vascular Hyperintensity and Cerebral Edema in Patients with Acute Ischemic Stroke

The presence of vascular hyperintensity on T2 FLAIR MRI was associated with nearly double the odds of cerebral edema, according to newly published research involving 855 patients with acute ischemic stroke.